Organigram Holdings Statistics

Total Valuation

Organigram Holdings has a market cap or net worth of CAD 230.20 million. The enterprise value is 153.47 million.

Market Cap	230.20M
Enterprise Value	153.47M

Important Dates

The next estimated earnings date is Thursday, December 19, 2024.

Earnings Date	Dec 19, 2024
Ex-Dividend Date	n/a

Share Statistics

Organigram Holdings has 108.59 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	108.59M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+18.89%
Owned by Insiders (%)	0.21%
Owned by Institutions (%)	6.77%
Float	75.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.16
PB Ratio	0.63
P/TBV Ratio	0.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.67
EV / Sales	1.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.45

Financial Position

The company has a current ratio of 6.95, with a Debt / Equity ratio of 0.02.

Current Ratio	6.95
Quick Ratio	2.85
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	-175.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	151,631
Profits Per Employee	-233,209
Employee Count	984
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.39% in the last 52 weeks. The beta is 1.13, so Organigram Holdings's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	+13.39%
50-Day Moving Average	2.31
200-Day Moving Average	2.47
Relative Strength Index (RSI)	39.94
Average Volume (20 Days)	220,144

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Organigram Holdings had revenue of CAD 149.21 million and -229.48 million in losses. Loss per share was -2.82.

Revenue	149.21M
Gross Profit	35.07M
Operating Income	-48.79M
Pretax Income	-233.00M
Net Income	-229.48M
EBITDA	-25.37M
EBIT	-48.79M
Loss Per Share	-2.82

Full Income Statement

Balance Sheet

The company has 33.86 million in cash and 4.72 million in debt, giving a net cash position of 29.15 million or 0.27 per share.

Cash & Cash Equivalents	33.86M
Total Debt	4.72M
Net Cash	29.15M
Net Cash Per Share	0.27
Equity (Book Value)	271.62M
Book Value Per Share	3.35
Working Capital	133.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -35.80 million and capital expenditures -26.90 million, giving a free cash flow of -62.70 million.

Operating Cash Flow	-35.80M
Capital Expenditures	-26.90M
Free Cash Flow	-62.70M
FCF Per Share	-0.58

Full Cash Flow Statement

Margins

Gross margin is 23.51%, with operating and profit margins of -32.70% and -153.80%.

Gross Margin	23.51%
Operating Margin	-32.70%
Pretax Margin	-156.16%
Profit Margin	-153.80%
EBITDA Margin	-17.00%
EBIT Margin	-32.70%
FCF Margin	-42.02%

Dividends & Yields

Organigram Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.26%
Shareholder Yield	-5.26%
Earnings Yield	-133.15%
FCF Yield	-27.24%

Stock Splits

The last stock split was on July 7, 2023. It was a reverse split with a ratio of 0.25.

Last Split Date	Jul 7, 2023
Split Type	Reverse
Split Ratio	0.25

Scores

Organigram Holdings has an Altman Z-Score of 4.15.

Altman Z-Score	4.15
Piotroski F-Score	n/a